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The Editorial on the Research Topic
Neurophysiology in Alzheimer’s Disease and Dementia
The aging of the nervous system is often associated with chronic diseases typical of old age,
which can offer in their pathogenesis, and in their susceptibility to particular therapies, the key
to understanding the determinants of senescence. In recent years, the need to distinguish normal
from pathological aging and the obligation to execute the diagnosis as early as possible, addressed
dementia research to the field of biomarkers. The biomarkers are easily recognizable, quantifiable,
and reproducible, biological entities, that can identify in a timely manner different profiles of
disease. It is widely believed in the scientific community that the diagnosis of Alzheimer’s disease
(AD) can be made early in the integrated analysis of structural, biological, clinical, and functional
biomarkers.
Neurophysiology, and in particular electroencephalography (EEG), has proved a reliable tool
in the biomarkers research of dementias. The ability to highlight the state of the underlying brain
network, even with very advance, the ease of application, the widespread reproducibility and, not
least, the low cost of operation, makes this method very suitable for studies of with a large number
of subjects.
In this special issue dedicated to the neurophysiology of dementia, contributions of different
cultural origins are presented, contributing to the general richness, and the scientific significance of
the issue.
Raymundo Cassani addressed the methodological aspect of removal of artifact from EEG,
demonstrating that a wavelet enhanced independent component analysis (wICA) algorithm alone
outperforms other methodics, thus opening the doors for fully-automated systems that can assist
clinicians with early detection of AD, as well as disease severity progression assessment.
Francesco Di Lorenzo, addressed the basic neurophysiological aspect of the cholinergic system
in AD through the theta burst stimulation (TBS) that modulate central cholinergic function using
the neurophysiological determination of Short-Latency Afferent Inhibition (SLAI). The SLAI was
decreased in AD patients compared to healthy controls (HS). Cerebellar TBS partially restored
SLAI in AD patients but did not modify SLAI in healthy subjects. These results demonstrate that
cerebellar magnetic stimulation affects cortical cholinergic activity and suggests that the cerebellum
could have a direct influence on the cholinergic damage in AD.
A lot of studies addressed the clinical aspect of the early diagnosis in AD.
Christos A. Frantzidis demonstrated an impaired organization of brain networks even in the
prodromal phase of Alzheimer’s disease (AD) due, in hypothesis, to compensation mechanisms.
Zhijie Bian proposed that the theta/alpha EEG power band ratio recorded in the frontal and
temporal region of the left hemisphere could be a diagnostic tool in patients with amnesic mild
cognitive impairment (aMCI) affected by diabetes.
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Simon-Shlomo Poil showed that EEG activity in the beta
frequency range (13–30 Hz) could be a helpful prognostic marker
to predict the conversion from the MCI state to the overt AD
condition. Of note, the authors found that the prediction power
is higher (sensitivity of 88% and specificity of 82%) when EEG
biomarkers are considered in an integrated way.
Davide V. Moretti demonstrated that the increase of EEG
alpha3/alpha2 power ratio is related with prodromal phase of AD.
The association with hippocampal atrophy, cortical thickness
and reduction of brain regional cerebral perfusion suggests that
alpha3/alpha2 power ratio could detect theMCI subjects who will
convert to AD.
Very interestingly, Natalya Ponomareva confirmed the
reliability of the increase of the EEG alpha3 spectral power
investigating the age-related influence of the polymorphism of
clusterin (CLU) genotype, associated with AD. In particular, the
homozygous variant of CLU C allele is related with the increase
of EEG alpha3 power, suggesting a possible susceptibility of this
genetic variant carriers to hippocampal atrophy.
Monica Lindin explored the field of event-related potentials
demonstrating that the Mismatch Negativity (MMN) amplitude
was significantly smaller in aMCI subjects than in healthy
controls.
Beyond EEG, also magnetoencephalography (MEG) could be
a useful research tool. Pilar Garcés found a pathological alpha
slowing in MCI patients when compared to healthy controls
investigating the changes in the spatial distribution of the
frequency and amplitude values of MEG alpha peak.
Finally, besides AD, Davide V. Moretti found that EEG
frequency rhythms are sensible also to different stage of
Fronto-Temporal-Dementia (FTD) and could detect changes
in brain oscillatory activity affected by progranulin (GRN)
mutations.
It is commonly thought that research in neuroscience is the
researcher’s effort to understand his own brain. If it is true, I
want to thank all the authors for helping me to understand also
something more of myself.
Somewhere, something incredible is waiting to be discovered (Cari
Sagan)
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